TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here.
ATS: Pirfenidone Slows IPF Lung DeclinesCourtesy MedPage Today Allergy & Immunology Tue, 05/20/2008 - 15:05
TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here. Popular products More related itemsLiving with a partner reduces risk of Alzheimer's
Allograft ACL Repair Questioned in Young Active Patients
Researcher say that ICSI may be over-used in some countries
Blood test for lung cancer may be possible
A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...
What Your Doctor May Not Tell You About Fibromyalgia: The...
Good Calories, Bad Calories
|
Popular by tags WeekMonth |
Post new comment